Correlation Between Aim Immunotech and Chembio Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aim Immunotech and Chembio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aim Immunotech and Chembio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aim Immunotech and Chembio Diagnostics, you can compare the effects of market volatilities on Aim Immunotech and Chembio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aim Immunotech with a short position of Chembio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aim Immunotech and Chembio Diagnostics.

Diversification Opportunities for Aim Immunotech and Chembio Diagnostics

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Aim Immunotech and Chembio is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Aim Immunotech and Chembio Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chembio Diagnostics and Aim Immunotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aim Immunotech are associated (or correlated) with Chembio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chembio Diagnostics has no effect on the direction of Aim Immunotech i.e., Aim Immunotech and Chembio Diagnostics go up and down completely randomly.

Pair Corralation between Aim Immunotech and Chembio Diagnostics

Considering the 90-day investment horizon Aim Immunotech is expected to generate 0.5 times more return on investment than Chembio Diagnostics. However, Aim Immunotech is 2.0 times less risky than Chembio Diagnostics. It trades about -0.1 of its potential returns per unit of risk. Chembio Diagnostics is currently generating about -0.26 per unit of risk. If you would invest  63.00  in Aim Immunotech on July 7, 2022 and sell it today you would lose (5.00)  from holding Aim Immunotech or give up 7.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy95.45%
ValuesDaily Returns

Aim Immunotech  vs.  Chembio Diagnostics

 Performance (%) 
       Timeline  
Aim Immunotech 
Aim Immunotech Performance
0 of 100
Over the last 90 days Aim Immunotech has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's forward indicators remain relatively steady which may send shares a bit higher in November 2022. The new chaos may also be a sign of medium-term up-swing for the company stakeholders.

Aim Immunotech Price Channel

Chembio Diagnostics 
Chembio Performance
0 of 100
Over the last 90 days Chembio Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in November 2022. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Chembio Price Channel

Aim Immunotech and Chembio Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aim Immunotech and Chembio Diagnostics

The main advantage of trading using opposite Aim Immunotech and Chembio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aim Immunotech position performs unexpectedly, Chembio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will offset losses from the drop in Chembio Diagnostics' long position.
Aim Immunotech vs. Ciena Corp
Aim Immunotech vs. Clearfield
Aim Immunotech vs. Commscope Holding
Aim Immunotech vs. Sierra Wireless IN
The idea behind Aim Immunotech and Chembio Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Chembio Diagnostics vs. Amazon Inc
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go